1. CTNI-16. TROTABRESIB (CC-90010, BMS-986378), A REVERSIBLE, POTENT ORAL BROMODOMAIN AND EXTRATERMINAL INHIBITOR (BETi) IN PATIENTS WITH HIGH-GRADE GLIOMAS: A PHASE 1 OPEN-LABEL 'WINDOW OF OPPORTUNITY' STUDY. (12th November 2021) Authors: Vogelbaum, Michael; Sepulveda, Juan Manuel; Reardon, David; Hanna, Bishoy; Filvaroff, Ellen; Aronchik, Ida; Amoroso, Barbara; Zuraek, Marlene; Sanchez-Perez, Tania; Mendez, Cristina; Nikolova, Zariana; Moreno, Victor Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CTNI-21. TROTABRESIB (CC-90010) IN COMBINATION WITH CONCOMITANT TEMOZOLOMIDE PLUS RADIOTHERAPY AND ADJUVANT TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA: UPDATED RESULTS FROM A PHASE 1B/2 STUDY. (14th November 2022) Authors: Vieito, Maria; Sepulveda, Juan Manuel; Moreno, Victor; de Vos, Filip; Geurts, Marjolein; Lorenzi, Elena; Macchini, Marina; van den Bent, Martin; Del Conte, Gianluca; Martín-Soberón, Maria Cruz; Brandal, Petter; Garcia, Maria Martinez; Amoroso, Barbara; Sanchez-Perez, Tania; Zuraek, Marlene; Hanna... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CTNI-51. ADJUVANT TROTABRESIB, A REVERSIBLE POTENT BROMODOMAIN AND EXTRATERMINAL INHIBITOR, PLUS TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA: INTERIM RESULTS FROM A PHASE 1B DOSE-FINDING STUDY. (12th November 2021) Authors: Vieito, Maria; Simonelli, Matteo; de Vos, Filip; Moreno, Victor; Geurts, Marjolein; Lorenzi, Elena; Macchini, Marina; van den Bent, Martin; Del Conte, Gianluca; de Jonge, Maja; Amoroso, Barbara; Sanchez-Perez, Tania; Zuraek, Marlene; Hanna, Bishoy; Aronchik, Ida; Filvaroff, Ellen; Mendez, Cristin... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma. Issue 1 (28th October 2022) Authors: Vieito, Maria; Simonelli, Matteo; de Vos, Filip; Moreno, Victor; Geurts, Marjolein; Lorenzi, Elena; Macchini, Marina; van den Bent, Martin J; Del Conte, Gianluca; de Jonge, Maja; Martín-Soberón, Maria Cruz; Amoroso, Barbara; Sanchez-Perez, Tania; Zuraek, Marlene; Hanna, Bishoy; Aronchik, Ida; Fil... Journal: Neuro-oncology advances Issue: Volume 4:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗